Glucocorticoid circadian rhythms in immune function
Adrenal glucocorticoid (GC) hormones are important regulators of energy metabolism, brain
functions, and the immune system. Their release follows robust diurnal rhythms and GCs …
functions, and the immune system. Their release follows robust diurnal rhythms and GCs …
Glucocorticoids and natural killer cells: a suppressive relationship
I Muscari, A Fierabracci, S Adorisio, M Moretti… - Biochemical …, 2022 - Elsevier
Glucocorticoids exert their pharmacological actions by mimicking and amplifying the function
of the endogenous glucocorticoid system's canonical physiological stress response. They …
of the endogenous glucocorticoid system's canonical physiological stress response. They …
Relacorilant+ nab-paclitaxel in patients with recurrent, platinum-resistant ovarian cancer: a three-arm, randomized, controlled, open-label phase II study
PURPOSE Despite therapeutic advances, outcomes for patients with platinum-
resistant/refractory ovarian cancer remain poor. Selective glucocorticoid receptor modulation …
resistant/refractory ovarian cancer remain poor. Selective glucocorticoid receptor modulation …
Overcoming taxane resistance: preclinical and phase 1 studies of relacorilant, a selective glucocorticoid receptor modulator, with nab-paclitaxel in solid tumors
PN Munster, AE Greenstein, GF Fleming… - Clinical Cancer …, 2022 - AACR
Purpose: Chemotherapy resistance remains a major problem in many solid tumors,
including breast, ovarian, and pancreatic cancer. Glucocorticoids are one potential driver of …
including breast, ovarian, and pancreatic cancer. Glucocorticoids are one potential driver of …
Outcome of immunotherapy in adrenocortical carcinoma: a retrospective cohort study
H Remde, L Schmidt-Pennington… - European Journal of …, 2023 - academic.oup.com
Objective Clinical trials with immune checkpoint inhibitors (ICI) in adrenocortical carcinoma
(ACC) have yielded contradictory results. We aimed to evaluate treatment response and …
(ACC) have yielded contradictory results. We aimed to evaluate treatment response and …
Autoimmune Disorders Associated With Surgical Remission of Cushing's Disease: A Cohort Study
DD Nyanyo, M Mikamoto, F Galbiati… - Annals of Internal …, 2024 - acpjournals.org
Background: Glucocorticoids suppress inflammation. Autoimmune disease may occur after
remission of Cushing's disease (CD). However, the development of autoimmune disease in …
remission of Cushing's disease (CD). However, the development of autoimmune disease in …
Heyndrickxia coagulans strain SANK70258 suppresses symptoms of upper respiratory tract infection via immune modulation: a randomized, double-blind, placebo …
M Aida, N Togawa, K Mizuyama, Y Aoki… - Frontiers in …, 2024 - frontiersin.org
Probiotic consumption strongly influences local intestinal immunity and systemic immune
status. Heyndrickxia coagulans strain SANK70258 (HC) is a spore-forming lactic acid …
status. Heyndrickxia coagulans strain SANK70258 (HC) is a spore-forming lactic acid …
Adjuvant therapy in adrenocortical carcinoma: prognostic factors and treatment options
R Al-Ward, C Zsembery, MA Habra - Endocrine Oncology, 2022 - eo.bioscientifica.com
Adrenocortical carcinoma (ACC) is a rare cancer with high recurrence rates and
heterogeneous clinical behavior. The role of adjuvant therapy remains unclear because of …
heterogeneous clinical behavior. The role of adjuvant therapy remains unclear because of …
[HTML][HTML] Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced …
AB Olawaiye, JW Kim, A Bagameri… - Journal of …, 2024 - ncbi.nlm.nih.gov
Background Ovarian cancer has the highest mortality among gynecologic cancers, primarily
because it typically is diagnosed at a late stage and because of the development of …
because it typically is diagnosed at a late stage and because of the development of …
The glucocorticoid receptor modulator relacorilant reverses the immunosuppressive effects of cortisol
AE Greenstein, HJ Hunt - International Immunopharmacology, 2023 - Elsevier
Cortisol, an endogenous glucocorticoid receptor (GR) agonist, controls a broad
transcriptional program that affects T-cell activation, pro-inflammatory cytokine secretion …
transcriptional program that affects T-cell activation, pro-inflammatory cytokine secretion …